http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015019637-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7b097bfd3f350ed27ffa53e1f114d1a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2cbec0734bbc5277d8cd57dfae39995 |
| publicationDate | 2015-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2015019637-A |
| titleOfInvention | Survivin cell analysis method, and cancer analysis method and drug efficacy screening method using the same |
| abstract | The present invention provides a method for cell analysis of intracellular kinetics and survivin promoter activity of survivin protein. The cell analysis method includes (1) a first vector including a survivin promoter and a gene encoding a photoprotein, and an expression vector including a promoter, a survivin gene, and a gene encoding a fluorescent protein. Preparing a second vector, (2) introducing the first vector and the second vector into a cell, (3) exposing the cell of (2) to a drug, (4) From the results of (5) and (4), performing the bright field observation, the fluorescence intensity measurement, and the luminescence intensity measurement, respectively, at at least two time points within the period before and after the cell is exposed to the drug. Obtaining information about the cells. [Selection] Figure 1 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023189236-A1 |
| priorityDate | 2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.